Heart signal T wave detection

By using electrodes and processing circuits to identify the T-wave end time of the heart signal in the cardiac signal analysis device, the accuracy of cardiac signal characteristic recognition is solved, and the prediction and treatment effect of rapid arrhythmias are improved.

CN112243387BActive Publication Date: 2024-11-22MEDTRONIC INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980037997.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-06-05
Filing Date
2019-06-03
Publication Date
2024-11-22
Estimated Expiration
2039-06-03

AI Technical Summary

Technical Problem

Existing cardiac signal analysis techniques are difficult to accurately identify the characteristics of cardiac signal, such as the end time of T waves, which affect the prediction and treatment effect of rapid arrhythmias.

Method used

The accuracy of cardiac signal characteristics is improved by sensing the cardiac signal using one or more electrodes in the device and determining the T-wave end time of the cardiac signal based on the unipolarity and area of ​​the representative signal.

Benefits of technology

It improves the accuracy of cardiac signal characteristics, enhances the predictive ability of rapid arrhythmias, reduces the damage to the heart by unnecessary defibrillation shocks, and provides more effective cardiac pacing therapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112243387B_ABST
    Figure CN112243387B_ABST
Patent Text Reader

Abstract

An example device for detecting one or more parameters of a cardiac signal is disclosed herein. The device includes one or more electrodes and a sensing circuit configured to sense the cardiac signal via the one or more electrodes. The device also includes a processing circuit configured to determine a representative signal based on the cardiac signal, the representative signal having a single polarity; and determine the end of a T wave of the cardiac signal based on an area under the representative signal.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to cardiac monitoring and, more particularly, to the evaluation of cardiac signal characteristics. Background Art

[0002] Cardiac signal analysis can be performed by various devices, such as implantable medical devices (IMDs) and external devices (e.g., smart watches, fitness monitors, mobile devices, Holter monitors, wearable defibrillators, etc.). For example, a device can be configured to process cardiac signals sensed by one or more electrodes (e.g., electrocardiograms (EGMs) and electrocardiograms (ECGs)). Features of cardiac signals may include P waves, Q waves, R waves, S waves, QRS complexes, and T waves. Accurate detection and depiction of features of cardiac signals (such as T waves) can be important for improving the operation of the device.

[0003] Cardiac pacing is delivered to patients for the treatment of a variety of cardiac dysfunctions. Cardiac pacing is typically delivered by an IMD. For example, an implantable cardioverter-defibrillator (ICD) can provide pacing functionality and, if necessary, can also provide cardioversion or defibrillation in response to detected cardiac tachyarrhythmias. However, pacemakers that do not provide anti-tachyarrhythmia shocks and ICDs that do not deliver pacing therapy are also common. An IMD typically delivers such therapy to the heart via electrodes located on one or more leads, which may be intracardiac or extracardiac leads, although leadless IMDs for delivering such therapy have also been implemented. In addition, leaded and leadless cardiac monitors that do not deliver therapy have also been implemented.

[0004] Patients with heart failure may receive cardiac resynchronization therapy (CRT). CRT is a form of cardiac pacing. The ventricles of some patients with heart failure contract in an uncoordinated or asynchronous manner, which greatly reduces the pumping efficiency of the ventricles. CRT delivers pacing pulses at specific times (e.g., atrioventricular (AV) intervals and / or intraventricular (VV) intervals) and specific locations (e.g., one or both of the right and left ventricles) to re-coordinate the contraction of the ventricles. In some examples, CRT involves delivering pacing pulses to both ventricles to synchronize their contractions. In other examples, CRT involves delivering pacing pulses to one ventricle (e.g., the left ventricle) to synchronize its contraction with that of the right ventricle. Summary of the invention

[0005] In general, the present disclosure is directed to devices and techniques for identifying one or more features and / or determining one or more parameters of a patient's cardiac signal (e.g., an EGM and / or ECG). For example, the present disclosure describes techniques for identifying the end of a T wave that may allow for a more robust depiction of cardiac signal features. This improved identification of the end of a T wave may, for example, allow for the determination of the variability of an activation recovery interval (ARI), e.g., a QT interval or an interval measured from the beginning of a QRS complex to the end of a T wave, which may predict whether a patient is experiencing or will experience a tachyarrhythmia. In some examples, an IMD may deliver therapy to a patient to terminate or prevent a predicted tachyarrhythmia, which therapy need not include anti-tachyarrhythmia shock. Signal processing techniques that may be used by, for example, a processing circuit system of an IMD to depict one or more features may include, for example, determining the area under a curve representing a signal that may be generated from a cardiac signal by derivation and have a unipolarity.

[0006] In one example, a device includes one or more electrodes; a sensing circuit configured to sense a cardiac signal via the one or more electrodes; and a processing circuit configured to determine a representative signal based on the cardiac signal, the representative signal having a unipolarity, and to determine the end of the T wave of the cardiac signal based on an area under the representative signal.

[0007] In another example, a method includes sensing a cardiac signal. The method also includes determining a representative signal based on the cardiac signal, the representative signal having a single polarity, and determining an end of a T wave of the cardiac signal based on an area under the representative signal.

[0008] In another example, a non-transitory computer-readable storage medium stores a set of instructions that, when executed, cause a system to sense a cardiac signal of a patient. The computer-readable storage medium may also cause the system to determine a representative signal based on the cardiac signal, the representative signal having a single polarity, and determine the end of a T wave of the cardiac signal based on an area under the representative signal.

[0009] In another example, a device includes one or more electrodes and a sensing circuit configured to sense a cardiac signal via the one or more electrodes. The device also includes a processing circuit configured to determine an end of a QRS complex of the cardiac signal, set a time window of the cardiac signal after the end of the QRS complex, determine a representative signal based on the cardiac signal and the time window, wherein the representative signal includes the square of the gradient of the cardiac signal within the window, and determine an end of a T wave of the cardiac signal based on an area under the representative signal, wherein the end of the T wave is given by a time when the area under the representative signal is approximately equal to a threshold portion of the total area under the representative signal. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 A conceptual diagram illustrating an example system for monitoring and treating cardiac events that may be used to identify one or more parameters of a cardiac electrogram (EGM) is provided.

[0011] Figure 2 To show in more detail Figure 1 Conceptual diagram of the IMD and leads of the system.

[0012] Figure 3 A block diagram is shown illustrating an example configuration of an IMD for monitoring and treating cardiac events that may be used to identify one or more parameters of a cardiac EGM.

[0013] Figure 4 is a block diagram illustrating an example configuration of an external device that may be used with an IMD to identify one or more parameters of a cardiac EGM.

[0014] Figure 5 To illustrate a block diagram of a system according to one or more aspects of the present disclosure, the system includes an external device such as a server, and one or more computing devices coupled to the IMD and the external device via a network.

[0015] Figure 6 2 is a flow chart illustrating a first example method of determining parameters of a cardiac EGM according to the techniques of the present disclosure.

[0016] Figure 7 is a block diagram illustrating an example cardiac signal analysis circuit that may be used to identify one or more parameters of a cardiac EGM in accordance with the techniques of this disclosure.

[0017] Figure 8 is a flow chart illustrating a second example method of determining parameters of a cardiac signal according to the techniques of this disclosure.

[0018] Fig. 9 2 is a voltage / time graph illustrating the QRS end time determined by an IMD according to the techniques of this disclosure.

[0019] Fig.10 2 is a voltage / time graph illustrating the T-wave end time determined by an IMD according to the techniques of the present disclosure. DETAILED DESCRIPTION

[0020] This disclosure describes techniques for identifying one or more parameters of a cardiac signal, such as the end time of a QRS complex and a T wave, that can be used, for example, to detect or predict arrhythmias, assess other conditions of a patient, or configure and / or assess a therapy such as CRT.

[0021] In some examples, the IMD may deliver therapy to the patient based on observable events (e.g., tachyarrhythmias) sensed by the cardiac EGM. Although some therapies, such as defibrillation shocks, can restore the patient's heart to normal function after a tachyarrhythmia is detected, the defibrillation shocks can be painful for the patient and cause permanent damage to the patient's cardiac tissue. In some cases, the patient may require hospitalization after the delivery of the defibrillation shock. For at least these reasons, it may be beneficial to improve the accuracy of the IMD in detecting the presence of arrhythmias in a patient, such as by increasing the accuracy of one or more parameters of the cardiac EGM measured by the IMD. In addition, it may be beneficial to predict tachyarrhythmias before they occur and deliver therapy (such as pacing) to prevent tachyarrhythmias, rather than terminating an ongoing tachyarrhythmia with an electric shock.

[0022] The techniques disclosed herein can improve the accuracy of a processing circuit in identifying one or more parameters of a cardiac signal acquired by a device, for example, the start and / or end time of one or more features of a cardiac signal (e.g., P wave start time, P wave end time, QRS complex start time, QRS complex end time, T wave start time and T wave end time), which can allow for more accurate characterization of these features. In some examples, the processing circuit can determine a representative signal of the cardiac signal by performing a signal processing method, the signal processing method including but not limited to filtering the cardiac signal, calculating the gradient of the cardiac signal, and amplifying the cardiac signal. The processing circuit can determine the end time of the QRS complex of the cardiac signal and the end time of a subsequent T wave in the cardiac signal based on the area under the representative signal calculated by the device. As an example, the T wave end time determined according to the techniques described herein can be used to, for example, determine the short-term variability (STV) of the activation recovery interval (ARI), which can in turn be used to predict tachyarrhythmias and / or determine whether CRT is effective.

[0023] In some examples, the techniques of the present disclosure may enable the use of a cardiac EGM acquired by an IMD rather than an electrocardiogram (ECG) by a processing circuit to identify an end time that accurately reflects the time when a corresponding event in the heart occurred. In addition, the computational complexity of the techniques described herein may be suitable for implementation by a processing circuit of an IMD. In other examples, the techniques of the present disclosure may enable accurate identification of features of an ECG acquired by an external device (such as, but not limited to, a smart watch, a fitness monitor, a mobile device, a Holter monitor, or a wearable defibrillator).

[0024] Figure 1 1 is a conceptual diagram illustrating an example system 10 for monitoring and treating cardiac events that may be used to identify one or more parameters of a cardiac electrogram (EGM). Figure 1As shown in the example system 10 in FIG. 1 , a system for identifying one or more parameters of a cardiac EGM according to the techniques of the present disclosure may include an IMD 16, which in the example shown is an ICD with pacing capabilities. The IMD 16 is connected to leads 18, 20, and 22 and is communicatively coupled to an external device 24. The IMD 16 senses electrical signals, such as EGMs, accompanying depolarization and repolarization of the heart 12 via electrodes on one or more leads 18, 20, and 22 or electrodes on the housing of the IMD 16. The IMD 16 may also deliver therapy to the heart 12 in the form of electrical signals via electrodes located on one or more leads 18, 20, and 22 or on the housing of the IMD 16. The therapy may be pacing, cardioversion, and / or defibrillation pulses. The IMD 16 may monitor the EGM signals collected by the electrodes on leads 18, 20, or 22, and diagnose and treat heart attacks based on the EGM signals.

[0025] Leads 18, 20, 22 extend into heart 12 of patient 14 to sense electrical activity of heart 12 and / or deliver electrical stimulation to heart 12. Figure 1 In the example shown, the right ventricle (RV) lead 18 extends through one or more veins (not shown), the superior vena cava (not shown), and the right atrium 26, and into the right ventricle 28. The left ventricle (LV) lead 20 extends through one or more veins, the vena cava, the right atrium 26, and into the coronary sinus 30 to a region adjacent to the free wall of the left ventricle 32 of the heart 12. The right atrium (RA) lead 22 extends through one or more veins and the vena cava, and into the right atrium 26 of the heart 12.

[0026] In some examples, external device 24 takes the form of a handheld computing device, a computer workstation, or a networked computing device that includes a user interface for presenting information to a user and receiving input from the user. A user, such as a physician, technician, surgeon, electrophysiologist, or other clinician, may interact with external device 24 to retrieve physiological or diagnostic information from IMD 16. The user may also interact with external device 24 to program IMD 16, e.g., to select values ​​for operating parameters of the IMD. External device 24 may include processing circuitry configured to evaluate EGM signals transmitted from IMD 16 to external device 24.

[0027] IMD 16 and external device 24 may communicate via wireless communications using any technology known in the art. Examples of communication technologies may include, for example, low frequency or radio frequency (RF) telemetry, or based on Or Bluetooth LE specification. In some examples, external device 24 may be located remotely from IMD 16 and communicate with IMD 16 via a network.

[0028] Figure 1The system 10 is an example of a system for identifying one or more parameters of a cardiac EGM according to the techniques of the present disclosure. In some examples, the processing circuitry of one or both of the IMD 16 and the external device 24 includes a cardiac signal analysis circuit configured to determine one or more parameters of a cardiac signal of the patient 14. In one example, the cardiac signal includes a cardiac EGM sensed via one or more electrodes of the IMD 16. The cardiac EGM is a signal representing the electrical activity of the heart, measured by electrodes implanted in the body (usually in the heart itself). For example, among other events, the cardiac EGM may include a P wave (depolarization of the atria), an R wave (depolarization of the ventricles), and a T wave (repolarization of the ventricles). Information related to the aforementioned events, such as the time to separate one or more events, can be used for a variety of purposes, such as determining whether an arrhythmia is occurring and / or predicting whether an arrhythmia is likely to occur. The cardiac signal analysis circuit, which may be implemented as part of the processing circuitry of the IMD 16 and / or the external device 24, may perform signal processing techniques to extract information indicating one or more parameters of the cardiac signal.

[0029] IMD 16 can be configured to determine the time of the beginning of the QRS complex wave representing the cardiac EGM, the time representing the end of the QRS complex wave, and the time representing the end of the subsequent T wave. In one example, IMD 16 is also configured to determine the QT interval (activation recovery interval (ARI)) as the time separating the beginning of the QRS complex wave and the end of the subsequent T wave. Subsequently, IMD 16 can measure multiple QT intervals, each of which corresponds to one of the multiple heartbeats. Multiple QT intervals and other parameters, such as but not limited to T wave duration and QRS duration, can predict an arrhythmia that is about to occur (e.g., within about one minute to about five minutes of the prediction) in patient 14. In response to determining that an arrhythmia will occur in patient 14, IMD 16 can deliver therapy to the heart 12 of patient 14 via one or more electrodes of leads 18, 20 and 22.

[0030] Although techniques for identifying one or more parameters of a cardiac EGM in accordance with the present disclosure are described herein primarily with reference to example system 10, the techniques may be performed by systems other than example system 10. For example, a system for identifying one or more parameters in accordance with the present disclosure may include an IMD having functionality different from IMD 16, and may include more, fewer, or different implantable cardiac leads than leads 18, 20, and 22. In some examples, the system for identifying one or more parameters includes more or fewer leads, does not include any intracardiac leads, or does not include any leads. In addition to the example of IMD 16 shown, example IMDs in which the present disclosure may be implemented include extracardiovascular ICDs, transcatheter pacing systems such as the Micra 300, commercially available from Medtronic plc, of Dublin, Ireland, and the like. TM Transcatheter pacing systems, and insertable cardiac monitors such as the Reveal LINQ available from Medtronic TM .

[0031] Figure 2 1 is a conceptual diagram of the IMD 16 and leads 18, 20, and 22 of the system 10 for illustrating in greater detail. In the example shown, bipolar electrodes 40 and 42 are positioned adjacent to the distal end of lead 18, and bipolar electrodes 48 and 50 are positioned adjacent to the distal end of lead 22. In addition, four electrodes 44, 45, 46, and 47 are positioned adjacent to the distal end of lead 20. Lead 20 may be referred to as a quadripolar LV lead. In other examples, lead 20 may include more or fewer electrodes. In some examples, LV lead 20 includes segmented electrodes, for example, wherein each of a plurality of longitudinal electrode positions of the lead, such as the positions of electrodes 44, 45, 46, and 47, includes a plurality of discrete electrodes arranged at corresponding circumferential positions around the circumference of the lead.

[0032] In the example shown, electrodes 40, 44-47, and 48 take the form of ring electrodes, and electrodes 42 and 50 may take the form of extendable spiral tip electrodes, which are telescopically mounted within insulating electrode heads 52 and 56, respectively. Leads 18 and 22 also include elongated electrodes 62 and 66, respectively, which may take the form of coils. In some examples, each of electrodes 40, 42, 44-48, 50, 62, and 66 is electrically coupled to a corresponding conductor within the lead body of its associated lead 18, 20, 22, and thereby coupled to circuitry within IMD 16.

[0033] In some examples, IMD 16 includes one or more housing electrodes, such as Figure 21 and 1 . A housing electrode 4 is shown, which may be integrally formed with an outer surface of gas-tight housing 8 of IMD 16 or otherwise coupled to housing 8. In some examples, housing electrode 4 is defined by an uninsulated portion of an outwardly facing portion of housing 8 of IMD 16. Other divisions between insulated and non-insulated portions of housing 8 may be used to define two or more housing electrodes. In some examples, the housing electrode includes substantially all of housing 8.

[0034] Housing 8 encloses signal generating circuitry that generates therapeutic stimulation (e.g., cardiac pacing, cardioversion, and defibrillation pulses), and sensing circuitry for sensing electrical signals associated with depolarization and repolarization of heart 12. Housing 8 may also enclose a memory for storing the sensed electrical signals. Housing 8 may also enclose telemetry circuitry for communication between IMD 16 and external device 24.

[0035] IMD 16 senses electrical signals accompanying depolarization and repolarization of heart 12 via electrodes 4, 40, 42, 44-48, 50, 62, and 66. IMD 16 may sense such electrical signals via any bipolar combination of electrodes 40, 42, 44-48, 50, 62, and 66. In addition, any of electrodes 40, 42, 44-48, 50, 62, and 66 may be combined with housing electrode 4 for unipolar sensing.

[0036] The number and configuration of leads 18, 20, and 22 and electrodes shown are examples only. Other configurations, i.e., the number and location of leads and electrodes, are also possible. In some examples, system 10 may include additional leads or lead segments having one or more electrodes located at different locations in the cardiovascular system for sensing and / or delivering therapy to patient 14. For example, instead of or in addition to intracardiac leads 18, 20, and 22, system 10 may include one or more extracardiac (e.g., epicardial, substernal, or subcutaneous) leads that are not positioned within the heart.

[0037] Figure 3A block diagram showing an example configuration of an IMD 16 for monitoring and treating cardiac events, which can be used to identify one or more parameters of a cardiac EGM according to the techniques of the present disclosure. In the example shown, the IMD 16 includes a processing circuit 70, a memory 72, a signal generating circuit 74, a sensing circuit 76, a telemetry circuit 78, a cardiac signal analysis circuit 80, and an activity sensor 82. The memory 72 includes computer-readable instructions that, when executed by the processing circuit 70, cause the IMD 16 and the processing circuit 70 to perform various functions attributed to the IMD 16 and the processing circuit 70 herein. The memory 72 may include any volatile, non-volatile, magnetic, optical, or electrical medium, such as a random access memory (RAM), a read-only memory (ROM), a non-volatile RAM (NVRAM), an electrically erasable programmable ROM (EEPROM), flash memory, or any other digital or analog medium.

[0038] Processing circuitry 70 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples, processing circuitry 70 may include multiple components, such as one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as any combination of other discrete or integrated logic circuitry. The functionality attributed herein to processing circuitry 70 may be embodied in software, firmware, hardware, or any combination thereof.

[0039] Typically, processing circuitry 70 controls signal generation circuitry 74 to deliver therapy to heart 12 of patient 14 according to selected values ​​of one or more therapy parameters that may be stored in memory 72. As an example, processing circuitry 70 may control signal generation circuitry 74 to deliver electrical pulses having an amplitude, pulse width, frequency, and / or electrode polarity specified by the selected therapy parameter values. The parameters stored in memory 72 include thresholds or other conditions that may be compared to parameters of the EGM and based on which processing circuitry 70 controls signal generation circuitry 74 to deliver therapy, such as heart rate, interval, and / or EGM morphology parameters.

[0040] The signal generation circuit 74 is configured to generate and deliver electrical therapy to the patient 14. Figure 3As shown, signal generation circuitry 74 is electrically coupled to electrodes 4, 40, 42, 44-48, 50, 62, and 66, e.g., via conductors of corresponding leads 18, 20, and 22, and, in the case of housing electrode 4, is electrically coupled to within housing 8. For example, signal generation circuitry 74 may deliver pacing, defibrillation, or cardioversion pulses to heart 12 via at least two of electrodes 4, 40, 42, 44-48, 50, 62, and 66. In some examples, signal generation circuitry 74 delivers therapy in the form of a signal other than a pulse, such as a sine wave, square wave, or other substantially continuous time signal.

[0041] Signal generation circuitry 74 may include one or more capacitors, charge pumps, current sources, or other signal generation circuits. Signal generation circuitry 74 may also include switching circuitry (not shown), and processing circuitry 70 may use the switching circuitry to select which of the available electrodes is used to deliver electrical stimulation, for example, via a data / address bus. The switching circuitry may include a switch array, a switch matrix, a multiplexer, or any other type of switching device suitable for selectively coupling energy to selected electrodes.

[0042] Electrical sensing circuitry 76 monitors electrical cardiac signals from any combination of electrodes 4, 40, 42, 44-48, 50, 62, and 66. Sensing circuitry 76 may also include switch circuitry that is controlled by processing circuitry 70 to select which of the available electrodes is used to sense cardiac activity, depending on which electrode combination is used in the current sensing configuration. In some examples, sensing circuitry 76 may include one or more amplifiers, filters, and analog-to-digital converters.

[0043] The sensing circuit 76 may include one or more detection channels, each of which may include an amplifier. The detection channels may be used to sense cardiac signals, such as cardiac EGM. Some detection channels may detect events, such as R waves, P waves, and T waves, and provide indications of the occurrence of such events to the processing circuit 70. One or more other detection channels may provide signals to an analog-to-digital converter for conversion to a digital signal for processing or analysis by the processing circuit 70 or the cardiac signal analysis circuit 80.

[0044] For example, the sensing circuit 76 may include one or more narrowband channels, each of which may include a narrowband filtered sense amplifier that compares the detected signal to a threshold. If the filtered and amplified signal is greater than the threshold, the narrowband channel indicates that a specific cardiac electrical event, such as a depolarization, has occurred. The processing circuit 70 then uses the detection to measure the frequency of the sensed event. In one example, at least one narrowband channel may include an R-wave or P-wave amplifier.

[0045] In some examples, the sensing circuit 76 includes a wideband channel, which may include an amplifier having a relatively wide passband compared to the narrowband channel. The signal from the electrode selected for coupling to the wideband amplifier can be converted to a multi-bit digital signal by an analog-to-digital converter (ADC) provided by, for example, the sensing circuit 76 or the processing circuit 70. The processing circuit 70 and the cardiac signal analysis circuit 80 can analyze the digitized version of the signal from the wideband channel. The processing circuit 70 can use digital signal analysis techniques to characterize the digitized signal from the wideband channel, for example, to detect and classify the patient's heart rhythm.

[0046] Processing circuit 70 may employ any of a variety of signal processing methods known in the art to detect and classify a patient's cardiac rhythm based on the cardiac electrical signals sensed by sensing circuit 76. For example, processing circuit 70 may maintain an escape interval counter that may be reset when an R wave is sensed by sensing circuit 76. When reset by a sensed depolarization, the count value present in the escape interval counter may be used by an episode classifier of processing circuit 70 to measure the duration of the RR interval, which is a measurement that may be stored in memory 72. Processing circuit 70 may use the count in the interval counter to detect a tachyarrhythmia, such as ventricular fibrillation or ventricular tachycardia. A portion of memory 72 may be configured as a plurality of recirculating buffers capable of holding a series of measured intervals that may be analyzed by processing circuit 70 to determine whether the patient's heart 12 is currently exhibiting an atrial or ventricular tachyarrhythmia.

[0047] In some examples, the processing circuit 70 may determine that a tachyarrhythmia has occurred by identifying a shortened RR interval length. For example, when the interval length is below a first threshold (e.g., 360 milliseconds (ms)), the processing circuit 70 detects tachycardia, and when the interval length is below a second threshold (e.g., 320ms), fibrillation is detected. These interval lengths are examples only, and the user may define the interval length as desired, which may then be stored in the memory 72. As an example, this interval length may need to be detected for a specific number of consecutive cycles, for a specific percentage of cycles within a running window, or for a running average of a specific number of cardiac cycles. In some examples, the arrhythmia detection method may include any combination of suitable tachyarrhythmia detection algorithms. For example, in order to detect or predict tachyarrhythmias, in addition to or in lieu of interval length, the use of EGM morphology may be considered.

[0048] Typically, the processing circuit 70 detects a treatable tachyarrhythmia, such as VF, based on the EGM (e.g., the RR intervals and / or morphology of the EGM), and selects a therapy to be delivered to terminate the tachyarrhythmia, such as an anti-tachycardia pacing regimen and / or a defibrillation pulse of a specific amplitude. Detection of a tachyarrhythmia may include multiple stages or steps prior to delivery of therapy, such as a first stage, sometimes referred to as detection, in which multiple consecutive or adjacent RR intervals meet a first number of interval detection (NID) criteria, and a second stage, sometimes referred to as confirmation, in which multiple consecutive or adjacent RR intervals meet a second, more stringent NID criteria. Tachyarrhythmia detection may also include confirmation based on EGM morphology or other sensors after or during the second stage.

[0049] One or more sensors 82 may optionally be included in some examples of IMD 16. Sensors 82 may include one or more accelerometers. Sensors 82 may additionally or alternatively include other sensors, such as a heart sound sensor, a pressure sensor, a flow sensor, or an oxygen (O2) saturation sensor. In some examples, processing circuit 70 may detect respiration via signals received from sensing circuit 76 via one or more electrodes.

[0050] As examples, information obtained from activity sensor 82 may be used to determine activity level, posture, blood pressure, blood flow, blood oxygen level, or respiratory rate. In some examples, IMD 16 may use this information to help classify abnormal heart rhythms. In some examples, a user of IMD 16 or external device 24 may use this information to determine desired LV pacing location and timing of delivery of CRT. For example, blood pressure or flow measurements may indicate the effectiveness of LV pacing location and timing in improving the performance of heart 12.

[0051] Sensor 82 may be located external to housing 8 of IMD 16. Sensor 82 may be located on a lead coupled to IMD 16, or may be implemented in a remote sensor that wirelessly communicates with IMD 16 via telemetry circuitry 78. In any case, sensor 82 is electrically or wirelessly coupled to circuitry contained within housing 8 of IMD 16.

[0052] In some examples, IMD 16 includes cardiac signal analysis circuit 80. Cardiac signal analysis circuit 80 and IMD 16 are configured to perform techniques for identifying one or more parameters of cardiac EGM, as described herein. Cardiac signal analysis circuit 80 may include software and / or firmware executed by processing circuit 70. Additionally or alternatively, cardiac signal analysis circuit 80 may include certain circuits of processing circuit 70. According to some examples, sensing circuit 76 senses cardiac signals (e.g., cardiac EGM) via any combination of electrodes 4, 40, 42, 44-48, 50, 62, and 66 of IMD 16. As described above, sensing circuit 76 may include a broadband amplifier, and sensing circuit 76 may sense cardiac signals with a broadband sensing amplifier. In response to detecting or predicting an arrhythmia based on one or more parameters identified by cardiac signal analysis circuit 80, IMD 16 may deliver therapy pulses to patient 14. In one example, under the control of processing circuitry 70 , signal generation circuitry 74 delivers therapy pulses to heart 12 via one or more electrodes (eg, 40 , 42 , 44 - 48 , 50 , 62 , and 66 ) of leads 18 , 20 , and 22 .

[0053] The cardiac signal analysis circuit 80 may include a microprocessor, a microcontroller, a DSP, an ASIC, an FPGA, or other equivalent discrete or integrated logic circuits. Therefore, the cardiac signal analysis circuit 80 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions attributed to the cardiac signal analysis circuit 80 herein. In one example, the cardiac signal analysis circuit 80 receives the cardiac EGM via the sensing circuit 76 (e.g., a broadband sensing channel of the sensing circuit 76) and any combination of electrodes 4, 40, 42, 44-48, 50, 62, and 66. Based on the representative signal of the cardiac EGM, the cardiac signal analysis circuit 80 may measure a plurality of QT intervals of the cardiac EGM, each of the plurality of QT intervals representing a time window between the start time of the QRS complex of the cardiac EGM and the end time of the T wave of the cardiac EGM (i.e., a time window between the start of ventricular depolarization and the end of ventricular repolarization). Additionally or alternatively, the cardiac signal analysis circuit 80 may measure other parameters, such as T wave duration (a time window separating the T wave start time and the T wave end time), QRS duration, and heart rate.

[0054] Parameters of the cardiac EGM measured by the cardiac signal analysis circuit 80 (e.g., QRS end time, T wave end time, QRS duration, T wave duration, QT interval length, etc.) may indicate that the patient 14 is about to develop an arrhythmia. Therefore, the IMD 16 may analyze the parameters of the cardiac EGM to predict potential imminent arrhythmias and deliver therapy to prevent the potential imminent arrhythmias. In one example, the IMD 16 may be configured to predict an impending arrhythmia between about one minute to about five minutes before the onset of the impending arrhythmia. After predicting the arrhythmia, the IMD 16 may deliver therapy to the heart 12 via the signal generation circuit 74. The IMD 16 may deliver therapy via any combination of electrodes 40, 42, 44-48, 50, 62, and 66. As Figure 3 As shown, IMD 16 may accurately measure parameters of the cardiac EGM by generating determinations of QRS complex start time, QRS complex end time, and T wave end time, as well as other parameters, that may be more accurate than determinations made by other techniques.

[0055] For example, the cardiac signal analysis circuit 80 can use a bandpass filter to create a filtered version of the EGM signal received from the sensing circuit 76. In one example, the bandpass filter can have a frequency pass range of 1 Hz to 10 Hz (e.g., the bandpass filter attenuates the frequency band outside the frequency passband range), thereby eliminating high-frequency noise and low-frequency noise in the cardiac EGM signal. In one example, noise can be introduced into the cardiac EGM signal by the respiratory system, muscle system, digestive system, nervous system, and other systems in the patient 14, as well as 60 Hz noise or other external noise at any frequency from external sources such as medical equipment or other machinery. The cardiac signal analysis circuit 80 or other components of the IMD 16 can detect the occurrence of R waves (e.g., ventricular depolarization events) in the EGM. For example, the sensing circuit 76 (e.g., a narrowband R wave detection channel within the sensing circuit) can provide an indication of the timing of R wave detection to the cardiac signal analysis circuit 80. The cardiac signal analysis circuit 80 may set a QRS window based on the detected R wave, the QRS window starting at a first time relative to the R wave and ending at a second time relative to the R wave, the first time and the second time of the QRS window being QRS window parameters 86 stored in the memory 72 of the IMD 16. In some examples, the first time and the second time of the QRS window both occur after the R wave. In other examples, at least one of the first time and the second time may occur before the R wave.

[0056] In one example, the first time occurs 10 milliseconds after the R wave, and the second time occurs 150 milliseconds after the R wave. In other examples, the first time and the second time of the QRS window may include other values. IMD 16 may update the QRS window parameter 86 in response to any of a variety of events. In some examples, IMD 16 may receive instructions from an external device 24 to update the QRS window parameter 86 (e.g., change the first time and the second time of the QRS window). Additionally or alternatively, the processing circuit 70 of IMD 16 may automatically update the QRS window parameter 86 in response to detecting a change in the heart rate of the patient 14. For example, if the heart rate of the patient 14 increases, the IMD 16 may reduce the length of the QRS window; and if the heart rate of the patient 14 decreases, the IMD 16 may increase the length of the QRS window. In other examples, IMD 16 may update the QRS window parameter 86 in response to other events, such as but not limited to signals from sensor (one or more) 82.

[0057] The QRS window may represent a period of time during which the end of the QRS complex is expected to occur. Therefore, when determining the end of the QRS complex, the IMD 16 may eliminate ("blank") the portion of the filtered EGM outside the QRS window. In addition, the IMD 16 may calculate the gradient of the filtered EGM signal, which is the derivative of the filtered EGM signal. A representative signal of the QRS complex may be calculated, the representative signal including the gradient of the filtered EGM signal. Additionally or alternatively, the representative signal of the QRS complex may include an amplification of the gradient of the filtered EGM signal. In one example, the representative signal includes an exponential (e.g., square, cubic, etc.) of the gradient of the filtered EGM signal. In one example, the representative signal may include a unipolarity (e.g., the representative signal may be exclusively positive or exclusively negative, however, the representative signal may not alternate between positive and negative polarities). For example, if the representative signal includes the square of the gradient of the filtered EGM signal, the square rectifies any negative portion of the representative signal, thereby presenting the representative signal of the QRS complex as a unipolarity. In other examples, IMD 16 may use a half-wave rectifier or a full-wave rectifier to create a representative signal having a single polarity. Additionally or alternatively, IMD 16 may perform an absolute value function, a magnitude function, etc. to determine a representative signal having a single polarity.

[0058] The cardiac signal analysis circuit 80 may determine the end of the QRS complex in the cardiac EGM signal based on the area under the representative signal of the QRS complex. In one example, the cardiac signal analysis circuit 80 is configured to calculate the total area under the representative signal of the QRS complex. In addition, the cardiac signal analysis circuit 80 is configured to calculate the area under any portion of the representative signal of the QRS complex, including any portion of the representative signal that begins at the first time of the QRS window and ends before the second time of the QRS window. The cardiac signal analysis circuit 80 is configured to determine the end of the QRS complex as the earliest determined time at which the area under the representative signal of the QRS complex is greater than or equal to a predetermined portion (e.g., a threshold portion) of the total area under the representative signal of the QRS complex. In one example, the portion of the total area under the representative signal of the QRS complex is 0.9. In other words, the cardiac signal analysis circuit 80 determines the end of the QRS complex as the first point within the QRS window where the area under the representative signal of the QRS complex is greater than or equal to 90% of the total area under the representative signal. In other examples, the portion of the total area under the representative signal of the QRS complex that indicates the end of the QRS complex may be greater or less than 0.9.

[0059] The portion of the total area under the representative signal of the QRS complex indicating the end of the QRS complex may be included in the signal region threshold(s) 84 stored in the memory 72 of the IMD 16. In one example, the IMD 16 may receive instructions from the external device 24 to change the signal region threshold(s) 84. In other examples, the IMD 16 may update the signal region threshold(s) 84 based on signals received from the sensor(s) 82, the processing circuit 70, or the cardiac signal analysis circuit 80.

[0060] As described above, the IMD 16 may detect an R wave, and the cardiac signal analysis circuit 80 may set a QRS window based on the detected R wave. Additionally or alternatively, the cardiac signal analysis circuit 80 may set a T wave window that starts at a first time relative to the R wave and ends at a second time relative to the R wave, the first time and the second time of the T wave window being T wave window parameters 88 stored in the memory 72 of the IMD 16. In some examples, the first time of the T wave window occurs at the QRS end time determined by the cardiac signal analysis circuit 80, and the second time of the T wave window occurs 700 milliseconds after the R wave. In other examples, the first time and the second time of the T wave window may include other values. The IMD 16 may update the T wave window parameters 88 based on any of a variety of events. In some examples, the IMD 16 may receive instructions from the external device 24 to update the T wave window parameters 88 (e.g., change the first time and the second time of the T wave window). Additionally or alternatively, the processing circuit 70 of the IMD 16 may automatically update the T wave window parameters 88 in response to detecting a change in the heart rate of the patient 14. For example, if the heart rate of patient 14 increases, IMD 16 may decrease the length of the T wave window; and if the heart rate of patient 14 decreases, IMD 16 may increase the length of the T wave window. In other examples, IMD 16 may update T wave window parameters 88 in response to other events, such as, but not limited to, signals from sensor(s) 82.

[0061] The T wave window may represent a period of time during which the end of the T wave is expected to occur. Therefore, when determining the end of the T wave complex, the IMD 16 may blank the portion of the filtered EGM outside the T wave window (e.g., the blanked portion may include the QRS complex before the T wave and the P wave after the T wave). In addition, the IMD 16 may calculate the gradient of the filtered EGM signal, which is the derivative of the filtered EGM signal. A representative signal of the T wave may be determined, the representative signal including the gradient of the filtered EGM signal. Additionally or alternatively, the representative signal may include an amplification of the gradient of the filtered EGM signal. In some examples, the representative signal includes an exponent (e.g., square, cube, etc.) of the gradient of the filtered EGM signal. In some examples, the representative signal may include a unipolarity (e.g., the representative signal may be exclusively positive or exclusively negative, however, the representative signal may not alternate between positive and negative polarities). For example, if the representative signal comprises the square of the gradient of the filtered EGM signal, then the square rectifies any negative portions of the representative signal, thereby rendering the representative signal of the T wave as unipolar.

[0062] The cardiac signal analysis circuit 80 may determine the end of the T wave in the cardiac EGM signal based on the area under the representative signal of the T wave. In one example, the cardiac signal analysis circuit 80 is configured to calculate the total area under the representative signal of the T wave. In addition, the cardiac signal analysis circuit 80 is configured to calculate the area under any portion of the representative signal of the T wave, including any portion of the representative signal that starts at the first time of the T wave window and ends before the second time of the T wave window. The cardiac signal analysis circuit 80 is configured to determine the end of the T wave as the earliest determined time, at which the area under the representative signal of the T wave is greater than or equal to a predetermined portion (e.g., a threshold portion) of the total area under the representative signal of the T wave. In one example, the portion of the total area under the representative signal of the T wave is 0.6. In other words, the cardiac signal analysis circuit 80 determines the end of the T wave as the first point within the T wave window, where the area under the representative signal of the T wave is equal to 60% of the total area under the representative signal. In other examples, the portion of the total area indicating the end of the T wave under the representative signal may be greater than or less than 0.6.

[0063] The portion representing the total area under the signal indicating the end of the T wave may be included in the signal area threshold(s) 84 stored in the memory 72 of the IMD 16. In one example, the IMD 16 may receive instructions from the external device 24 to change the signal area threshold(s) 84. In other examples, the IMD 16 may update the signal area threshold(s) 84 based on signals received from the sensor(s) 82, the processing circuit 70, or the cardiac signal analysis circuit 80.

[0064] The cardiac signal analysis circuit 80 may also be configured to measure one or more parameters of the P wave (e.g., atrial depolarization events). For example, the cardiac signal analysis circuit 80 may measure the P wave start time, P wave end time, and P wave duration based on the area under the representative signal of the corresponding P wave. Additionally or alternatively, the cardiac signal analysis circuit 80 or the processing circuit 70 may measure the PR interval (e.g., the time window separating the P wave start time and the R wave peak) and other intervals based on the parameters measured using the techniques of the present disclosure. The cardiac signal analysis circuit 80 may be configured to calculate any combination of derivatives, integrals, gradients, exponents, variances, amplitudes, magnitudes, and other mathematical operations of any portion of the cardiac EGM signal recorded by the IMD 16.

[0065] The processing circuit 70 and the cardiac signal analysis circuit 80 may be combined in a single processing unit. The cardiac signal analysis circuit 80 may be a component of the processing circuit 70, or may be a software or firmware module executed by the processing circuit.

[0066] Telemetry circuit 78 includes any suitable hardware, firmware, software, or any combination thereof, for communicating with external device 24 ( Figure 1 ) to communicate with another device. Under the control of processing circuitry 70, telemetry circuitry 78 may receive downlink telemetry from external device 24 and send uplink telemetry to an external device via an antenna, which may be internal and / or external. In some examples, processing circuitry 70 may transmit cardiac signals generated by sensing circuitry 76, such as EGM signals.

[0067] The processing circuit 70 may also generate and store marker codes indicating different cardiac or other physiological events detected by the sensing circuit 76, the processing circuit 70, or the cardiac signal analysis circuit 80, and transmit the marker codes to the external device 24. The information that the processing circuit 70 may transmit to the external device 24 via the telemetry circuit 78 may also include an indication of a change in cardiac disease state, an indication of a change in the heart's response to a provided therapy, or an indication that the heart continues to respond in the same (or similar) manner to the provided therapy. Such information may be included as part of the marker channel of the EGM.

[0068] Figure 4 2 is a block diagram illustrating an example configuration of external device 24 that may be used with IMD 16 to identify one or more parameters of the cardiac EGM. Figure 4 As shown, external device 24 may include processing circuitry 90, memory 96, telemetry circuitry 92, user interface 94, and cardiac signal analysis circuitry 80. External device 24 is an example of an external computing device that communicates with an IMD to perform the disclosed techniques for identifying one or more parameters of a cardiac EGM.

[0069] Processing circuitry 90 stores information and instructions to and retrieves information and instructions from memory 96. Processing circuitry 90 may include a microprocessor, microcontroller, DSP, ASIC, FPGA, or other equivalent discrete or integrated logic circuitry. Thus, processing circuitry 90 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions attributed herein to processing circuitry 90.

[0070] The memory 92 may include program instructions that, when executed by the processing circuit 90 and / or the cardiac signal analysis circuit 80, cause the processor and / or the cardiac signal analysis circuit to perform any of the functions attributed to them herein. The memory 96 may also include instructions for operating the user interface 94 and the telemetry circuit 92. The memory 96 may include any volatile or non-volatile memory, such as RAM, ROM, EEPROM, or flash memory. The memory 96 may also include a removable memory portion that can be used to provide memory updates or increases in memory capacity. The removable memory may also allow sensitive patient data to be removed before the external device 24 is used by or for a different patient.

[0071] Telemetry circuitry 92 receives data from IMD 16 and may provide program instructions from processing circuitry 90 to IMD 16. In various examples, telemetry circuitry 92 includes any of a variety of circuits known to facilitate wireless (e.g., radio frequency or inductive) communication with IMD 16. In some examples, processing circuitry 90 receives an indication from IMD 16 that the variance of the QT interval of the cardiac EGM of patient 14 is above a threshold variance value, thereby indicating an arrhythmia. Processing circuitry 90 may present an indication of the arrhythmia to a user (e.g., a physician, surgeon, or other clinician) via user interface 94. User interface 94 may also allow a user to view and change signal region thresholds 84, QRS window parameters 86, and T wave window parameters 88. As Figure 4 As shown, the memory 96 may store the signal region threshold 84, the QRS window parameter 86, and the T wave window parameter 88. In other examples, the memory 96 may store Figure 4 Data not shown.

[0072] In other examples, such as Figure 4 As shown, external device 24 includes cardiac signal analysis circuitry 80, and cardiac signal analysis circuitry 80 and external device 24 are configured to perform substantially as described above with respect to IMD 16 and Figure 3 Techniques for identifying parameters of a cardiac EGM are described. For example, external device 24 may receive a cardiac EGM from IMD 16 via telemetry circuit 92, and processing circuit 90 may use information about the cardiac EGM. Figure 3 The described techniques are used to process the cardiac EGM to determine multiple QT intervals of the cardiac EGM. Additionally or alternatively, the cardiac EGM may be processed in part by the IMD 16 and in part by the external device 24 (e.g., the QRS start time and T wave end time are determined by the IMD 16, and the variance of the multiple QT intervals is determined by the external device 24).

[0073] The user interface 94 includes a display (not shown), such as an LCD or LED display or other type of screen, to present any indication or information described herein of the technology for identifying cardiac signal parameters according to the present disclosure. In addition, the user interface 94 may include an input mechanism to receive input from a user. The input mechanism may include, for example, a button, a keypad (e.g., an alphanumeric keypad), a peripheral pointing device, or another input mechanism that allows a user to browse a user interface presented by the processing circuit 90 of the external device 24 and provide input. The input may include, for example, instructions for controlling the IMD 16, the external device 24, and the cardiac signal analysis circuit 80 in the execution of the technology for identifying cardiac signal parameters according to the present disclosure. In some examples, the display (not shown) of the external device 24 may be a touch screen that allows a user to provide input directly to the user interface displayed on the display. The user may use a stylus or a finger to provide input to the display. In other examples, the user interface 94 additionally or alternatively includes an audio circuit for providing audible instructions or sounds to the user and / or receiving voice commands from the user.

[0074] The processing circuit 90 and the cardiac signal analysis circuit 80 may be combined in a single processing unit. The cardiac signal analysis circuit 80 may be a component of the processing circuit 90 or a module executed by the processing circuit.

[0075] In some examples, a system for identifying arrhythmias includes any of a variety of networked external computing devices, such as a server, an external device, and a client computing device coupled via a network. In some aspects, such a system may be used with the Medtronic 3D Imaging System developed by Medtronic, Inc., of Minneapolis, MN. In such examples, any one or more external computing devices of such a system may include cardiac signal analysis circuitry, or may individually or collectively perform any of the techniques for identifying parameters of a cardiac signal described herein.

[0076] Figure 5 A block diagram of a system 140 according to one example is shown, which includes an external device 142 such as a server and one or more computing devices 144A-144N coupled to the IMD 16 and the external device 24 via a network 150. In this example, the IMD 16 communicates with the external device 24 via a first wireless connection using communication circuitry, and communicates with the access point 152 via a second wireless connection. Figure 5In the example of FIG. 1 , access point 152, external device 24, server 142, and computing devices 144A-144N are interconnected and capable of communicating with each other via network 150. In some cases, one or more of access point 152, external device 24, external device 142, and computing devices 144A-144N may be coupled to network 150 via one or more wireless connections. IMD 16, external device 24, external device 152, and computing devices 144A-144N may each include one or more processing circuits, such as one or more microprocessors, DSPs, ASICs, FPGAs, programmable logic circuits, etc., that may perform various functions and operations, such as those described herein.

[0077] Access point 152 may include a device that connects to network 150 via any of a variety of connections, such as a telephone dial-up, a digital subscriber line (DSL), or a cable modem connection. In other examples, access point 152 may be coupled to network 150 via different forms of connections, including wired or wireless connections. In some examples, access point 152 may communicate with external device 24 and / or IMD 16. Access point 152 may be co-located with patient 14 (e.g., in the same room or in the same location as patient 14), or may be located remotely from patient 14. For example, access point 152 may be a home monitor located in the patient's home, or a portable monitor that is conveniently carried by patient 14.

[0078] During operation, IMD 16 may collect, measure, and store various forms of diagnostic data. For example, IMD 16 may collect cardiac EGM and motion signal data. In some cases, IMD 16 may directly analyze the collected diagnostic data and generate any corresponding reports or alarms. However, in some cases, IMD 16 may send diagnostic data to external device 24, access point 152, and / or external device 142 wirelessly or via access point 152 and network 150 for remote processing and analysis. For example, IMD 16 may send data indicating whether patient 14 is about to develop an arrhythmia to external device 24. External device 24 may generate a report or alarm after analyzing the data.

[0079] In another example, IMD 16 may provide the collected EGM and motion signal data, system integrity indications, and any other relevant physiological or system data to external device 142 via access point 152 and network 150. External device 142 includes one or more processing circuits 148. In some cases, external device 142 may request such data, and in some cases, IMD 16 may automatically or periodically provide such data to external device 142. After receiving the diagnostic data via input / output device 146, external device 142 may analyze the data and generate a report or alert.

[0080] In one example, external device 142 may comprise a secure storage site for information that has been collected from IMD 16 and / or external device 24. In this example, network 150 may comprise the Internet; and trained professionals, such as clinicians, may use computing devices 144A-144N to securely access data stored on external device 142. For example, the trained professionals may need to enter a username and password to access information stored on external device 142. In one embodiment, external device 142 may be a Medtronic RFID reader provided by Medtronic Inc. of Dublin, Ireland. server.

[0081] In some examples, processing circuitry and memory of one or more of access point 152, server 142, or computing device 144, such as processing circuitry 148 and memory of server 142, may be configured to provide some or all of the functionality of the processing circuitry and memory attributed to IMD 16. For example, processing circuitry 148 of server 142 may determine the end of a QRS complex and the end of a T wave of a cardiac EGM signal received at server 142. Additionally or alternatively, server 142 may determine other parameters of the cardiac EGM. In response to determining the parameters of the cardiac EGM, server 142 may deliver instructions to IMD 16 via network 150 and access point 152 and / or external device 24 to deliver therapy to patient 14.

[0082] Figure 6 FIG. 6 is a flow chart illustrating a first example method 600 of determining parameters of a cardiac EGM according to the techniques of the present disclosure. Figure 6 In an example method, a cardiac EGM is sensed (610). In one example, an IMD 16 senses a cardiac EGM. As described herein, the IMD 16 may include leads 18, 20, and 22 having electrodes 40, 42, 44-48, 50, 62, and 64. In addition, the housing 8 of the IMD 116 may include electrode 4. Any combination of these electrodes may be configured to sense a cardiac EGM. In addition, any combination of a processing circuit 70 of the IMD 16 and a processing circuit 90 of an external device 24 may be configured to receive the sensed cardiac EGM. Subsequently, a cardiac signal analysis circuit 80 determines a representative signal based on the cardiac EGM (620). In one example, the representative signal defines a unipolarity. In addition, the end of the T wave of the cardiac EGM may be determined, for example, by the cardiac signal analysis circuit 80 (630). In one example, the cardiac signal analysis circuit 80 determines the end of the T wave based on the area below the representative signal.

[0083] Figure 71 is a block diagram of an example cardiac signal analysis circuit 700 that can be used to identify one or more parameters of a cardiac EGM according to the techniques of the present disclosure. Figure 3 or Figure 4 An example of a cardiac signal analysis circuit 80. The cardiac signal analysis circuit 700 may include an EGM preprocessing module 710, an EGM signal 712, a sampling rate 714, a filtered EGM signal 716, a QRS delineation module 720, a QRS window start time 722, a QRS window end time 724, a QRS complex wave end time 726, a T wave delineation module 730, a T wave window start time 732, a T wave window end time 734, and a T wave end time 736. The EGM preprocessing module 710, the QRS delineation module 720, and the T wave delineation module 730 may be implemented in one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic QRS circuits, and any combination of such components. The term "module" may generally refer to any of the aforementioned logic circuits, alone or in combination with other logic circuits or any other equivalent circuits, and alone or in combination with other digital or analog circuits. Although Figure 7 The example shown in describes analysis of cardiac EGM signals sensed by implantable electrodes, but the techniques described herein can be used to analyze other cardiac signals, such as an ECG recorded by external electrodes.

[0084] The EGM preprocessing module 710 may be configured to receive an EGM signal 712 sensed by the sensing circuit 76 via electrodes of the IMD 16. The EGM signal 712 may represent a cardiac EGM signal including noise from various sources. The preprocessing module 710 may be configured to sample the EGM signal 712 at a sampling rate 714, generating a discrete EGM signal that can be modified using the signal processing techniques described herein. In one example, the EGM preprocessing module 710 may include a Butterworth filter that defines a bandpass filter with a frequency range extending from 1 Hz to 10 Hz. Therefore, low-frequency noise and high-frequency noise may be filtered out from the EGM signal by the EGM preprocessing block 710. Examples of noise may include respiratory activity, muscle activity, gastrointestinal activity, and noise from other systems of the human body. Other examples of noise may include 60 Hz noise, white noise, or other external noise of any frequency from external sources such as medical equipment or other machinery. The Butterworth filter is an infinite impulse response (IIR) filter that can be designed to have a flat frequency response (e.g., the signal is uniformly attenuated between frequencies not passed by the filter). Additionally or alternatively, the EGM preprocessing module 710 may include any combination of an IIR filter, a finite impulse response (FIR) filter, a high pass filter, a low pass filter, a notch filter, a Chebyshev filter, an elliptical filter, a Bessel filter, a Gaussian filter, a Linkwitz-Riley filter, and the like.

[0085] The EGM preprocessing module 710 may generate a filtered EGM signal 716. Since the filter of the EGM preprocessing module 710 is configured to remove noise from the EGM signal 712, the filtered EGM signal 716 may enhance one or more features of the cardiac EGM signal that were previously obscured in the EGM signal 712. For example, events such as P waves, QRS complexes, and T waves may be more visible in the filtered EGM signal 716 than in the EGM signal 712. Therefore, parameters of the cardiac EGM may be more detectable in the filtered EGM signal 716 than in the EGM signal 712.

[0086] The QRS delineation module 720 may receive a filtered EGM signal 716 from the EGM preprocessing module 710. In addition, the QRS delineation module 720 may sample the filtered EGM signal 716 at a sampling rate 714. The QRS delineation module 720 may be configured to output a QRS complex end time 726, the output representing the time at which the detected QRS complex ends in the cardiac EGM signal. Initially, the QRS delineation module 720 may set a QRS window indicating a time period in which the QRS complex is expected to end in a future portion of the cardiac EGM signal. For example, the QRS delineation module 720 may detect an R wave in the filtered EGM signal 716, or receive an indication of an R wave detection by other circuits of the IMD 16. Subsequently, the QRS delineation module may set the QRS window to start from a QRS window start time 722 and extend to a QRS window end time 724. In one example, the QRS window start time 722 occurs 10 milliseconds after the detected R wave, and the QRS window end time 724 occurs 150 milliseconds after the detected R wave. In other examples, the QRS window start time 722 and the QRS window end time 724 may include other values. The QRS delineation module 720 may eliminate (e.g., "blank") all portions of the filtered EGM signal 716 outside the QRS window.

[0087] After the QRS depiction module 720 blanks the filtered EGM 716 signal outside the QRS window, the QRS depiction module 720 can calculate the gradient of the filtered EGM signal 716 within the QRS window (e.g., calculating the slope of the filtered EGM signal 716 at each point in the entire QRS window). The gradient can be a real-time derivative calculation. In some examples, the QRS depiction module 720 can limit the representative signal to the gradient of the filtered EGM signal 716. In other examples, the QRS depiction module 720 can amplify the gradient of the filtered EGM signal 716, thereby creating a representative signal of the QRS complex wave. In other examples, the QRS depiction module 720 can amplify the gradient of the filtered EGM signal 716 by calculating the exponent of the gradient (e.g., square, cube, etc.). The representative signal of the QRS complex wave may include a unipolarity, which means that the polarity of the representative signal does not change in the entire QRS window. For example, the representative signal may include a completely negative or completely positive value, but the representative signal does not alternate between positive and negative values.

[0088] The QRS delineation module 720 may determine a QRS complex end time 726, the output representing the time at which the QRS complex in the patient's cardiac EGM ends. In calculating the QRS complex end time 726, the QRS delineation module 720 may evaluate the area under the representative signal of the QRS complex. For example, the QRS delineation module 720 may determine the end of the QRS complex as the earliest determined time at which the area under the representative signal of the QRS complex is greater than or equal to a threshold portion of the total area under the representative signal of the QRS complex. The area under the representative signal of the QRS complex may be evaluated at each point along the representative signal. In one example, the threshold portion of the total area under the representative signal is 0.9.

[0089] The filtered EGM signal 716 may define a discrete signal having a plurality of data points spaced apart at the sampling rate 714. Thus, the representative signal of the QRS complex may also define a discrete signal, and the QRS delineation module 720 may calculate the area under the representative signal at each of the plurality of data points. In one example, the area of ​​any portion of the representative signal within the QRS window may be calculated by performing a summation of the data points starting from the data point at the beginning of the QRS window and ending with a data point indicating the end of the corresponding portion of the representative signal of the QRS complex.

[0090] The T wave depiction module 730 may receive the filtered EGM signal 716 from the EGM preprocessing module 710. When the T wave depiction module 730 receives the filtered EGM signal 716, the module may sample the filtered EGM signal 716 at a sampling rate 714. The T wave depiction module 730 may be configured to output a T wave end time 736. In particular, the T wave end time 736 represents the time at which the T wave ends in the cardiac EGM signal. Like the QRS depiction module 720, the T wave depiction module 730 may set a time window. For example, the T wave depiction module 730 may set a T wave window that indicates a time period when the T wave is expected to end in a future portion of the cardiac EGM signal. For example, the T wave depiction module 730 may detect an R wave in the filtered EGM signal 716. Subsequently, the T wave depiction module 730 may set a T wave window starting from the T wave window start time 722 and extending to the T wave window end time 724. In one example, the T wave window start time 732 occurs at the QRS complex end time 726 calculated by the QRS delineation module 720, and the T wave window end time 734 occurs 700 milliseconds after the detected R wave. In other examples, the T wave window start time 732 and the T wave end time 734 may include other values. The T wave delineation module 730 may eliminate (e.g., "blank") all portions of the filtered EGM signal 716 outside of the T wave window.

[0091] After the T wave depiction module 730 blanks the filtered EGM signal 716 outside the T wave window, the T wave depiction module 730 may calculate the gradient of the filtered EGM signal 716 within the T wave window (e.g., calculate the slope of the filtered EGM signal 716 at each point in the entire T wave window). The gradient may be a real-time derivative calculation. In some examples, the T wave depiction module 730 may define the representative signal of the T wave as the gradient of the filtered EGM signal 716. In other examples, the T wave depiction module 730 may amplify the gradient of the filtered EGM signal 716, thereby creating a representative signal of the T wave. In other examples, the T wave depiction module 730 may amplify the gradient of the filtered EGM signal 716 by calculating the exponent of the gradient (e.g., square, cube, etc.). The representative signal of the T wave may include a unipolarity, which means that the polarity of the representative signal does not change throughout the T wave window. For example, the representative signal may include a value that is completely negative or completely positive, but the representative signal does not alternate between positive and negative values.

[0092] The T wave delineation module 730 may determine a T wave end time 736. In calculating the T wave end time 736, the T wave delineation module 730 may be configured to evaluate the area under the representative signal of the T wave. For example, the T wave delineation module 730 may determine the end of the T wave as the earliest determined time at which the area under the representative signal of the T wave is greater than or equal to a threshold portion of the total area under the representative signal of the T wave. The area under the representative signal of the T wave may be evaluated at each point along the representative signal. In one example, the threshold portion of the total area under the representative signal is 0.6. The representative signal of the T wave may be a discrete signal, and the area under any portion of the representative signal may be determined by performing a summation of all data points within the corresponding portion of the representative signal.

[0093] Figure 8 FIG. 8 is a flow chart illustrating a second example method 800 for determining parameters of a cardiac signal according to the techniques of the present disclosure. Figure 8 In an example, a cardiac signal is sensed (810). In some examples, the cardiac signal may be a cardiac EGM sensed by an IMD (such as IMD 16). In other examples, the cardiac signal may be an ECG sensed by electrodes of an external device (such as a smart watch, a fitness monitor, a mobile device, a Holter monitor, a wearable defibrillator, etc.). The cardiac signal is filtered to produce a filtered cardiac signal (820). An R wave is detected (830), and a time window (840) is set based on the detected R wave. In one example, the time window starts at a first time relative to the detected R wave and ends at a second time relative to the detected R wave. A representative signal (850) is determined based on the filtered cardiac signal within the time window, and the end of the T wave of the cardiac signal is determined based on the area under the representative signal (860).

[0094] In one example, IMD 16 senses cardiac EGM, filters EGM, detects R wave, sets time window, determines representative signal, and determines end of T wave. As described herein, IMD 16 may include leads 18, 20, and 22 with electrodes 40, 42, 44-48, 50, 62, and 64. Additionally or alternatively, other devices such as external device 24 or server 142 may perform Figure 8 Any combination of steps.

[0095] Fig. 9 9 is a voltage / time graph 900 showing a QRS complex end time 940 determined by IMD 16 according to the techniques of the present disclosure. Voltage / time graph 900 also shows a cardiac EGM signal 910, a filtered EGM signal 920, a representative signal 930, and a QRS end time 940. EGM signal 910 may be Figure 7 The filtered EGM signal 920 may be Figure 7 An example of a filtered EGM signal 716, and the QRS complex end time 940 may be Figure 7 An example of a QRS complex end time 726.

[0096] exist Fig. 9 In the example shown, the cardiac EGM signal 910 is sensed by the IMD 16 via one or more electrodes and the sensing circuit 76. The cardiac EGM signal 910 is filtered to determine a filtered EGM signal 920, and a representative signal 930 is determined based on the filtered EGM signal 920. In one example, the representative signal 930 is based on a QRS window that is based on an R wave detected in the cardiac EGM signal 910. The QRS window starts at a first time relative to the detected R wave and ends at a second time relative to the detected R wave. The representative signal 930 having a unipolarity may be defined by the gradient of the filtered EGM signal 920 within the QRS window. Additionally or alternatively, the representative signal 930 may be defined by an amplification of the gradient of the filtered EGM signal 920 within the QRS window. The QRS complex end time 940 may be calculated based on the earliest determined time at which the area under the representative signal 930 is greater than or equal to a threshold portion of the total area under the representative signal 930. As shown in FIG. Fig. 9 As shown, the QRS complex end time 940 is located at a small fraction of the total duration of the representative signal 930 , yet the QRS complex end time 940 is an accurate representation of the end of the QRS complex of the cardiac EGM signal 910 .

[0097] Fig.101000 is a voltage / time graph showing a T wave end time 1040 determined by IMD 16 according to the techniques of the present disclosure. Voltage / time graph 1000 also shows a cardiac EGM signal 1010, a filtered EGM signal 1020, a representative signal 1030, and a QRS end time 1040. EGM signal 1010 may be Figure 7 Example of EGM signal 712, the filtered EGM signal 1020 may be Figure 7 An example of a filtered EGM signal 716, and the T wave end time 1040 may be Figure 7 An example of T wave end time 736.

[0098] The cardiac EGM signal 1010 may be filtered to produce a filtered EGM signal 1020. Subsequently, a T wave window may be set that starts at a first time relative to a detected R wave and ends at a second time relative to a detected R wave. In one example, the first time is the end time of the QRS complex wave, such as Fig. 9 The QRS complex end time 940. The representative signal 1030 having a unipolarity may be defined by the gradient of the filtered EGM signal 1020 within the T wave window. Additionally or alternatively, the representative signal 1030 may be defined by amplifying the gradient of the filtered EGM signal 1020. The T wave window may be different from Fig. 9 The QRS window, therefore, represents the signal 1030 may be different from Fig. 9 The T wave end time 1040 may be calculated based on the earliest determined time at which the area under the representative signal 1030 is greater than or equal to a threshold portion of the total area under the representative signal 1030. Fig.10 As shown, the T wave end time 1040 is located at a small fraction of the total duration of the representative signal 1030, however the T wave end time 1040 is an accurate representation of the end of the T wave of the cardiac EGM signal 910.

[0099] The techniques described in the present disclosure may be implemented at least in part in hardware, software, firmware, or any combination thereof. For example, various aspects of these techniques may be implemented in one or more processors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic QRS circuits, and any combination of such components, which are embodied in external devices (such as physician or patient programmers, simulators, or other devices). The terms "processor", "processing circuit", "controller", or "control module" may generally refer to any of the aforementioned logic circuits, either alone or in combination with other logic circuits or any other equivalent circuits, and either alone or in combination with other digital or analog circuits.

[0100] For aspects implemented in software, at least some of the functionality attributed to the systems and devices described in this disclosure may be embodied as instructions on a non-transitory computer-readable storage medium (e.g., RAM, ROM, NVRAM, EEPROM, flash memory, magnetic media, optical media, etc.). These instructions may be executed to support one or more aspects of the functionality described in this disclosure.

Claims

1. A cardiac signal T wave detection device, the device comprising: one or more electrodes; a sensing circuit configured to sense a cardiac signal via the one or more electrodes; and A processing circuit configured to: A representative signal is determined based on the cardiac signal, the representative signal having a single polarity, wherein The representative signal comprises a gradient of the cardiac signal, and The end of the T wave of the cardiac signal is determined based on the area under the representative signal. 2 . The apparatus according to claim 1 , wherein the representative signal comprises an index of the gradient of the cardiac signal. 3 . The apparatus according to claim 2 , wherein the index of the gradient of the cardiac signal comprises the square of the gradient of the cardiac signal.

4. The apparatus of claim 1 , wherein the processing circuit determines the end of the T wave as the earliest determined time at which the area under the representative signal is greater than or equal to a threshold portion of the total area under the representative signal. The apparatus of claim 4 , wherein the threshold portion of the total area under the representative signal is 0.

6.

6. The apparatus according to any one of claims 1 to 5, wherein the processing circuit is further configured to: determining an end of a QRS complex of the cardiac signal; and The representative signal is determined based on a time window of the cardiac signal after the end of the QRS complex, wherein the time window begins at a first time and ends at a second time.

7. The apparatus of claim 6, wherein the processing circuit is further configured to detect an R wave of the cardiac signal, and the first time is the end of the QRS complex, and the second time is 700 milliseconds after the detected R wave.

8. The apparatus of claim 6, wherein the processing circuit is configured to: determining a heart rate based on the heart signal; If the heart rate increases, then reducing the length of the time window; and If the heart rate decreases, the length of the time window is increased.

9. The device according to claim 6, wherein the representative signal comprises a first representative signal, and The processing circuit is further configured to: determining a second representative signal based on the cardiac signal, the second representative signal having a single polarity; and The end of the QRS complex of the cardiac signal is determined based on the area under the second representative signal.

10. The apparatus of claim 9, wherein the time window comprises a first time window, and wherein in determining the end of the QRS complex, the processing circuit is configured to: detecting an R wave in the QRS complex; setting a second time window after the detected R-wave, wherein the second time window begins at a first time relative to the detected R-wave and ends at a second time relative to the detected R-wave; and The second representative signal is determined based on the second time window of the cardiac signal.

11. Apparatus according to claim 9 or 10, wherein the second representative signal comprises an index of a gradient of the cardiac signal.

12. The apparatus of claim 9 or 10, wherein the end of the QRS complex is the earliest determined time at which the area under the second representative signal is greater than or equal to a fraction of the total area under the second representative signal.

13. The apparatus of claim 12, wherein the portion of the total area under the second representative signal is 0.

9.

14. The device according to any one of claims 1 to 5, wherein the device including the one or more electrodes is configured to be implanted in a patient, and wherein the cardiac signal comprises a cardiac electrogram.